• Home
  • Study Details
By physician referral or invitation only

Biobank for COVID-19 Convalescent Samples

The purpose of this research study is to understand if convalescent plasma is a potential therapy and to understand the immune response to COVID-19 infection. Understanding the immune system's response after infection will help to inform vaccine design and the potential role of antibodies as therapeutics in the setting of COVID-19 infection and disease.

Age & Gender

  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Luther Bartelt
Medicine-Infectious Diseases

Study Type

Clinical or Medical
Observational

Study Topics

Immune System/Infections
COVID-19

IRB Number

20-1141

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research